Combined, these findings indicate that caspase-2 is involved in the maintenance of adipocyte size, function and glucose homeostasis and importantly that caspase-2 deficiency can improve adipose function and protects from HFD-induced obesity, NAFLD and fatty liver. The gene discussed is CASP2; the disease is obesity due to melanocortin 4 receptor deficiency.